• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    1/20/23 11:02:17 AM ET
    $ARQQ
    $BAX
    $BKD
    $CRON
    Computer Software: Prepackaged Software
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ARQQ alert in real time by email

     

    Friday saw 23 companies set new 52-week lows.

    Significant Points From Today's 52-Week Lows:

    • L3Harris Technologies (NYSE:LHX) was the largest firm by market cap to set a new 52-week low.
    • The smallest company on a market cap basis to set a new 52-week low was Digital Brands Group (NASDAQ:DBGI).
    • Windtree Therapeutics (NASDAQ:WINT) saw the most pronounced move, as shares traded down 26.62% to hit its new 52-week low.
    • Arqit Quantum (NASDAQ:ARQQ) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low.

    Stocks that set new 52-week lows on Friday are as follows:

    • L3Harris Technologies (NYSE:LHX) stock set a new 52-week low of $190.11 on Friday, moving down 0.2%.
    • Hormel Foods (NYSE:HRL) stock hit $44.10 on Friday morning, setting a new 52-week low for a change of down 0.29%.
    • Baxter Intl (NYSE:BAX) stock hit a yearly low of $43.25. The stock was down 0.02% for the day.
    • Globant (NYSE:GLOB) stock dropped to a yearly low on Friday of $154.53. Shares traded down 0.11%.
    • National Fuel Gas (NYSE:NFG) stock dropped to a yearly low on Friday of $57.60. Shares traded down 0.95%.
    • Lumen Technologies (NYSE:LUMN) stock broke to a new 52-week low of $4.96 on Friday. Shares of the company traded up 1.62%.
    • Intellia Therapeutics (NASDAQ:NTLA) stock dropped to a yearly low on Friday of $32.44. Shares traded down 1.68%.
    • Granite Ridge Resources (NYSE:GRNT) stock broke to a new 52-week low of $7.83 on Friday. Shares of the company traded down 1.26%.
    • Cronos Group (NASDAQ:CRON) stock hit a new 52-week low of $2.39. The stock was down 0.62% on the session.
    • Skyward Specialty (NASDAQ:SKWD) stock hit $17.50 on Friday morning, setting a new 52-week low for a change of down 2.39%.
    • Brookdale Senior Living (NYSE:BKD) shares hit a yearly low of $2.37. The stock was up 1.86% on the session.
    • Domo (NASDAQ:DOMO) shares hit a yearly low of $11.35. The stock was down 9.87% on the session.
    • Arqit Quantum (NASDAQ:ARQQ) stock hit a yearly low of $2.02. The stock was 0.0% (flat) for the day.
    • KNOT Offshore Partners (NYSE:KNOP) stock broke to a new 52-week low of $5.54 on Friday. Shares of the company traded down 2.62%.
    • Rite Aid (NYSE:RAD) stock broke to a new 52-week low of $3.17 on Friday. Shares of the company traded up 1.88%.
    • FaZe Holdings (NASDAQ:FAZE) shares were down 7.96% for the day, having made a 52-week low of $0.92.
    • Lipella Pharmaceuticals (NASDAQ:LIPO) stock broke to a new 52-week low of $2.59 on Friday. Shares of the company traded up 1.51%.
    • Tricida (NASDAQ:TCDA) shares set a new 52-week low of $0.12. The stock traded down 3.82%.
    • Windtree Therapeutics (NASDAQ:WINT) shares were down 26.62% for the day, having made a 52-week low of $0.14.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ARQQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARQQ
    $BAX
    $BKD
    $CRON

    CompanyDatePrice TargetRatingAnalyst
    Lumen Technologies Inc.
    $LUMN
    2/4/2026Outperform → Mkt Perform
    Raymond James
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    Globant S.A.
    $GLOB
    1/6/2026$72.00Hold
    Truist
    Brookdale Senior Living Inc.
    $BKD
    1/6/2026$13.00Underperform → Buy
    BofA Securities
    L3Harris Technologies Inc.
    $LHX
    12/16/2025$367.00Equal-Weight → Overweight
    Morgan Stanley
    L3Harris Technologies Inc.
    $LHX
    12/12/2025$331.00Buy
    Citigroup
    KNOT Offshore Partners LP
    $KNOP
    12/8/2025Buy → Neutral
    Alliance Global Partners
    Globant S.A.
    $GLOB
    11/20/2025$61.00Buy → Hold
    Jefferies
    More analyst ratings

    $ARQQ
    $BAX
    $BKD
    $CRON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Johnson Kathleen E bought $499,925 worth of shares (78,685 units at $6.35), increasing direct ownership by 0.93% to 8,562,582 units (SEC Form 4)

    4 - Lumen Technologies, Inc. (0000018926) (Issuer)

    2/5/26 5:34:09 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Director Cohen Fred E bought $1,402,500 worth of shares (150,000 units at $9.35), increasing direct ownership by 261% to 207,453 units (SEC Form 4)

    4 - Intellia Therapeutics, Inc. (0001652130) (Issuer)

    1/7/26 4:05:06 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Chase William J bought $1,003,000 worth of shares (100,000 units at $10.03), increasing direct ownership by 288% to 134,693 units (SEC Form 4)

    4 - Intellia Therapeutics, Inc. (0001652130) (Issuer)

    8/22/25 4:30:14 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group Pres., ITT & Pharma. Soriano Maria Cecilia was granted 2,273 shares and covered exercise/tax liability with 918 shares, increasing direct ownership by 2% to 56,006 units (SEC Form 4)

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    2/11/26 7:11:08 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    EVP and General Counsel Rosenbloom David S. was granted 17,055 shares and covered exercise/tax liability with 5,225 shares, increasing direct ownership by 11% to 119,464 units (SEC Form 4)

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    2/11/26 7:10:01 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    EVP,Group Pres,Healthcare Rasul Reazur was granted 18,951 shares and covered exercise/tax liability with 5,770 shares, increasing direct ownership by 10% to 139,846 units (SEC Form 4)

    4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)

    2/11/26 7:08:56 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hormel Foods Names Will Bonifant Group Vice President and Chief Supply Chain Officer

    Seasoned supply chain leader to oversee global procurement, manufacturing, planning, logistics and engineering AUSTIN, Minn., Feb. 12, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced the appointment of Will Bonifant as group vice president and chief supply chain officer, effective March 9. In this role, Bonifant will lead the company's global supply chain, including procurement, manufacturing, planning, logistics, engineering and supply chain innovation. "Will is a proven supply chain leader who has scaled co

    2/12/26 5:00:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Globant to Announce Fourth Quarter 2025 Financial Results on February 26th

    LUXEMBOURG, Feb. 12, 2026 /PRNewswire/ -- Globant (NYSE:GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will release results for the fourth quarter and full year ended December 31st, 2025 on Thursday, February 26th, 2026 after the close of regular market hours. Following the earnings release, Martin Migoya, Globant's Chief Executive Officer & co-founder, Diego Tártara, Chief Technology Officer, Juan Urthiague, Chief Financial Officer, and Fernando Matzkin, Chief Revenue Officer, will discuss the re

    2/12/26 4:15:00 PM ET
    $GLOB
    EDP Services
    Technology

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lumen Technologies downgraded by Raymond James

    Raymond James downgraded Lumen Technologies from Outperform to Mkt Perform

    2/4/26 8:28:23 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Truist initiated coverage on Globant with a new price target

    Truist initiated coverage of Globant with a rating of Hold and set a new price target of $72.00

    1/6/26 8:56:40 AM ET
    $GLOB
    EDP Services
    Technology

    $ARQQ
    $BAX
    $BKD
    $CRON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 18, 2024 - FDA Roundup: October 18, 2024

    For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

    10/18/24 4:16:25 PM ET
    $NVCR
    $BAX
    Medical/Dental Instruments
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    SEC Filings

    View All

    SEC Form S-3ASR filed by L3Harris Technologies Inc.

    S-3ASR - L3HARRIS TECHNOLOGIES, INC. /DE/ (0000202058) (Filer)

    2/12/26 5:08:39 PM ET
    $LHX
    Industrial Machinery/Components
    Industrials

    SEC Form 10-K filed by Baxter International Inc.

    10-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

    2/12/26 4:46:04 PM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Intellia Therapeutics Inc.

    SCHEDULE 13G/A - Intellia Therapeutics, Inc. (0001652130) (Subject)

    2/12/26 2:39:36 PM ET
    $NTLA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Leadership Updates

    Live Leadership Updates

    View All

    Hormel Foods Names Will Bonifant Group Vice President and Chief Supply Chain Officer

    Seasoned supply chain leader to oversee global procurement, manufacturing, planning, logistics and engineering AUSTIN, Minn., Feb. 12, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, today announced the appointment of Will Bonifant as group vice president and chief supply chain officer, effective March 9. In this role, Bonifant will lead the company's global supply chain, including procurement, manufacturing, planning, logistics, engineering and supply chain innovation. "Will is a proven supply chain leader who has scaled co

    2/12/26 5:00:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    Lumen Technologies Appoints Jeff Sharritts as Chief Revenue Officer

    Veteran leader to deepen customer relationships, sharpen execution, and scale company's commercial engine in Lumen's next phase of transformation Lumen Technologies (NYSE: LUMN) today announced that Jeff Sharritts has been appointed Executive Vice President and Chief Revenue Officer, effective Feb. 4, 2026. He will report to Lumen CEO Kate Johnson and will lead Lumen's commercial strategy, including the Acceleration and Growth Team, with a focus on deepening customer relationships and driving profitable growth for the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260203640994/en/LUMN) as EVP and Chief Revenue Officer

    2/3/26 4:01:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Hormel Foods Taps Domenic Borrelli as Executive Vice President of Retail, Bringing Extensive Category Leadership to Iconic Brand Portfolio

    AUSTIN, Minn., Jan. 15, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, today announced the appointment of Domenic Borrelli as executive vice president of Retail, effective February 23, 2026. In this role, Borrelli will oversee the Retail business unit, which includes many of the company's most recognized consumer brands and represents one of its largest growth engines. "I am delighted to welcome Domenic to the company. He has a proven track record of creating consumer-driven growth in well-established, legacy businesses an

    1/15/26 4:30:00 PM ET
    $HRL
    Meat/Poultry/Fish
    Consumer Staples

    $ARQQ
    $BAX
    $BKD
    $CRON
    Financials

    Live finance-specific insights

    View All

    Globant to Announce Fourth Quarter 2025 Financial Results on February 26th

    LUXEMBOURG, Feb. 12, 2026 /PRNewswire/ -- Globant (NYSE:GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced it will release results for the fourth quarter and full year ended December 31st, 2025 on Thursday, February 26th, 2026 after the close of regular market hours. Following the earnings release, Martin Migoya, Globant's Chief Executive Officer & co-founder, Diego Tártara, Chief Technology Officer, Juan Urthiague, Chief Financial Officer, and Fernando Matzkin, Chief Revenue Officer, will discuss the re

    2/12/26 4:15:00 PM ET
    $GLOB
    EDP Services
    Technology

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Baxter Reports Fourth-Quarter 2025 Results

    Fourth-quarter sales from continuing operations of $2.97 billion increased 8% on a reported basis and 3% on an operational basis1,2 Fourth-quarter U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($2.01); adjusted diluted EPS from continuing operations of $0.44 Company advances ongoing board of directors refreshment Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter of 2025. "While we delivered sales growth across all segments, our fourth-quarter results did not meet our expectations, underscoring the importance of our focus on driving continuous improvement across the enterprise," said And

    2/12/26 7:15:00 AM ET
    $BAX
    Medical/Dental Instruments
    Health Care

    $ARQQ
    $BAX
    $BKD
    $CRON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/10/24 8:05:26 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Windtree Therapeutics Inc.

    SC 13G/A - WINDTREE THERAPEUTICS INC /DE/ (0000946486) (Subject)

    11/14/24 7:15:44 PM ET
    $WINT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care